174 related articles for article (PubMed ID: 23450709)
1. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn.
Liu Y; Dong J; Mu R; Gao Y; Tan X; Li Y; Li Z; Yang G
Arthritis Rheum; 2013 Jun; 65(6):1603-11. PubMed ID: 23450709
[TBL] [Abstract][Full Text] [Related]
2. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.
Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
Arthritis Rheum; 2005 Dec; 52(12):3955-65. PubMed ID: 16320343
[TBL] [Abstract][Full Text] [Related]
3. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus.
Ding S; Liang Y; Zhao M; Liang G; Long H; Zhao S; Wang Y; Yin H; Zhang P; Zhang Q; Lu Q
Arthritis Rheum; 2012 Sep; 64(9):2953-63. PubMed ID: 22549634
[TBL] [Abstract][Full Text] [Related]
4. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
5. TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.
Liu F; Fan H; Ren D; Dong G; Hu E; Ji J; Hou Y
Eur J Immunol; 2015 Jul; 45(7):1934-45. PubMed ID: 25929465
[TBL] [Abstract][Full Text] [Related]
6. Downregulated miR‑29a promotes B cell overactivation by upregulating Crk‑like protein in systemic lupus erythematosus.
Shi X; Ye L; Xu S; Guo G; Zuo Z; Ye M; Zhu L; Li B; Xue X; Lin Q; Ding X
Mol Med Rep; 2020 Aug; 22(2):841-849. PubMed ID: 32467986
[TBL] [Abstract][Full Text] [Related]
7. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a Targets Notch1 to Alleviate Podocyte Injury in Lupus Nephritis.
Guo A; Sun Y; Xu X; Xing Q
Immunol Invest; 2022 Aug; 51(6):1694-1706. PubMed ID: 35023444
[TBL] [Abstract][Full Text] [Related]
9. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
Liossis SN; Solomou EE; Dimopoulos MA; Panayiotidis P; Mavrikakis MM; Sfikakis PP
J Investig Med; 2001 Mar; 49(2):157-65. PubMed ID: 11288756
[TBL] [Abstract][Full Text] [Related]
10. Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus.
Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
Arthritis Rheum; 2007 Jan; 56(1):291-302. PubMed ID: 17195233
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4
Chen S; Wang Y; Qin H; Lin J; Xie L; Chen S; Liang J; Xu J
Lupus; 2019 Apr; 28(4):510-519. PubMed ID: 30760089
[TBL] [Abstract][Full Text] [Related]
12. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.
Vásquez A; Baena A; González LA; Restrepo M; Muñoz CH; Vanegas-García A; Ortiz-Reyes B; Abdoel N; Rojas M; García LF; Vásquez G
Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855
[TBL] [Abstract][Full Text] [Related]
13. B cell receptor signaling in human systemic lupus erythematosus.
Pugh-Bernard AE; Cambier JC
Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.
Ramanujan SA; Cravens EN; Krishfield SM; Kyttaris VC; Moulton VR
Arthritis Rheumatol; 2021 Nov; 73(11):2052-2058. PubMed ID: 33982889
[TBL] [Abstract][Full Text] [Related]
15. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.
Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB
Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
[TBL] [Abstract][Full Text] [Related]
18. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
[TBL] [Abstract][Full Text] [Related]
19. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
